Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation

被引:32
作者
Grossmann, R
Ebell, JB
Misoph, M
Schwender, S
Neukam, K
Hickethier, T
Elert, O
Keller, F
机构
[1] Central Laboratory, University Medical Centre, University Hospital, D-97080 Würzburg
[2] Department of Cardiothoracic Surgery, University Hospital, D-97080 Würzburg
关键词
extracorporeal circulation; Coagulation; fibrinolysis; aprotinin;
D O I
10.1007/BF01747190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During cardiopulmonary bypass (CPB) mechanical stress and the contact of blood with artificial surfaces lead to the activation of pro- and anticoagulant systems and the complement cascade, and to changes in cellular components. This phenomenon causes the ''postperfusion-syndrome'', with leukocytosis, increased capillary permeability, accumulation of interstitial fluid, and organ dysfunction. In this study, we focused on the influence of the extracorporeal circulation, sternotomy, and heparin administration on the activation of coagulation and fibrinolysis. In 15 patients we investigated coagulation parameters before, during and post CPB, i.e., fibrinogen, antithrombin (AT) III, thrombin-antithrombin complex (TAT), prothrombin fragments F1 + 2 (F1 + 2), factor (F) XIIa, tissue factor (TF), and parameters of the fibrinolytic system, i.e., plasmin-antiplasmin-complex (PAP), D-dimer, tissue-plasminogen-activator (tPA), urokinase-type plasminogen activator (uPA), and plasminogen-activator inhibitor type 1 (PAI 1). The results demonstrate distinct alterations in the above mentioned parameters. Despite administration of a high dose of heparin (activated clotting time [ACT] > 450 s) combined with a low dose of aprotinin, activation of the coagulation and fibrinolytic pathways was observed. We found this activation was mainly caused by CPB and not by sternotomy. The activation of coagulation was due to foreign surface contact (F XII double right arrow F XIIa) as well as to an effect of tissue factor release in the late phase of CPB. The enhanced fibrinolytic activity during CPB was, at least in part, caused by tPA and was followed by PAI 1 release.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 37 条
[1]  
BABINEBELL J, 1995, Z HERZ THORAX GEFASS, V9, P196
[2]   CARDIOPULMONARY BYPASS USING CENTRIFUGAL PUMP [J].
BERKI, T ;
GURBUZ, A ;
ISIK, O ;
AKKAYA, H ;
BAYEZID, O ;
YAKUT, C .
VASCULAR SURGERY, 1992, 26 (02) :123-134
[3]  
BICK R L, 1975, Vascular Surgery, V9, P228, DOI 10.1177/153857447500900407
[4]  
BOISCLAIR MD, 1993, BLOOD, V82, P3350
[5]  
BOROWIEC J, 1992, J THORAC CARDIOV SUR, V104, P642
[6]   ACTIVATION OF PRO-UROKINASE BY THE HUMAN T-CELL-ASSOCIATED SERINE PROTEINASE HUTSP-1 [J].
BRUNNER, G ;
SIMON, MM ;
KRAMER, MD .
FEBS LETTERS, 1990, 260 (01) :141-144
[7]   INFLAMMATORY RESPONSE TO CARDIOPULMONARY BYPASS [J].
BUTLER, J ;
ROCKER, GM ;
WESTABY, S .
ANNALS OF THORACIC SURGERY, 1993, 55 (02) :552-559
[8]   EFFECT OF CARDIOPULMONARY BYPASS ON SYSTEMIC RELEASE OF NEUTROPHIL ELASTASE AND TUMOR-NECROSIS-FACTOR [J].
BUTLER, J ;
PILLAI, R ;
ROCKER, GM ;
WESTABY, S ;
PARKER, D ;
SHALE, DJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 105 (01) :25-30
[9]  
CASEY LC, 1993, ANN THORAC SURG, V56, P592
[10]  
CASH JD, 1976, PROGR CHEM FIBRINOLY, P65